{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:49:58Z","timestamp":1761490198448},"reference-count":26,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2017]]},"DOI":"10.3164\/jcbn.16-77","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T22:09:26Z","timestamp":1486505366000},"page":"143-145","source":"Crossref","is-referenced-by-count":10,"title":["Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy"],"prefix":"10.3164","volume":"60","author":[{"given":"Takashi","family":"Kawai","sequence":"first","affiliation":[{"name":"Gastroenterological Endoscopy, Tokyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of General Medicine and Primary Care, Tokyo Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Oguchi","sequence":"additional","affiliation":[{"name":"Shinjuku NS Building Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Shinjuku Mitsui Building Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Matushita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, International Catholic Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kitayama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tokyo Shinjuku Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tokyo Shinjuku Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Hiratsuka","sequence":"additional","affiliation":[{"name":"Hiratsuka Gastroenterological Hospital Shinjuku Center Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ohata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NTT Medical Center Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tokyo Women\u2019s Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Kishino","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tokyo Women\u2019s Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tokyo Women\u2019s Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Manabe N, Haruma K, Kamada T, et al. Changes of upper gastrointestinal symptoms and endoscopic findings in Japan over 25 years. Intern Med 2011; 50: 1357\u20131363.","DOI":"10.2169\/internalmedicine.50.4731"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kimura Y, Kamiya T, Senoo K, et al. Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients. J Clin Biochem Nutr 2016; 59: 71\u201377.","DOI":"10.3164\/jcbn.16-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Arihiro S, Kato T, Ito K, et al. Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms. J Clin Biochem Nutr 2012; 50: 205\u2013210.","DOI":"10.3164\/jcbn.11-71"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900\u20131920.","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"5","unstructured":"5 Japanese Society of Gastroenterology. Therapeutic Guidelines for Gastroesophageal Reflux Disease (GERD). Tokyo: Nankodo, 2009."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Mizuno H, Matsuhashi N, Sakaguchi M, et al. Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan. J Clin Biochem Nutr 2015; 57: 233\u2013238.","DOI":"10.3164\/jcbn.14-144"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next? Aliment Pharmacol Ther 2005; 22: 79\u201394.","DOI":"10.1111\/j.1365-2036.2005.02531.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Katz PO, Ginsberg GG, Hoyle PE, Sostek MB, Monyak JT, Silberg DG. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis. Aliment Pharmacol Ther 2007; 25: 617\u2013628.","DOI":"10.1111\/j.1365-2036.2006.03235.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Bretagne JF, Honnorat C, Richard-Molard B, Caekaert A, Barth\u00e9lemy P. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther 2006; 23: 607\u2013616.","DOI":"10.1111\/j.1365-2036.2006.02811.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Miwa H, Koseki J, Oshima T, et al. Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J Gastroenterol 2010; 45: 478\u2013487.","DOI":"10.1007\/s00535-009-0180-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Tominaga K, Iwakiri R, Fujimoto K, et al.; GERD 4 Study Group. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol 2012; 47: 284\u2013292.","DOI":"10.1007\/s00535-011-0488-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Hongo M, Kinoshita Y, Shimozuma K, Kumagai Y, Sawada M, Nii M. Psychometric validation of the Japanese translation of the Quality of Life in Reflux and Dyspepsia questionnaire in patients with heartburn. J Gastroenterol 2007; 42: 807\u2013815.","DOI":"10.1007\/s00535-007-2098-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009; 44: 518\u2013534.","DOI":"10.1007\/s00535-009-0047-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100: 283\u2013289.","DOI":"10.1111\/j.1572-0241.2005.41210.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Furuta T, Shirai N, Watanabe F, et al. Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin Pharmacol Ther 2002; 72: 453\u2013460.","DOI":"10.1067\/mcp.2002.127637"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Peghini PL, Katz PO, Bracy NA, Castell DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93: 763\u2013767.","DOI":"10.1111\/j.1572-0241.1998.221_a.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Siddiqui A, Rodriguez-Stanley S, Zubaidi S, Miner PB Jr. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig Dis Sci 2005; 50: 81\u201385.","DOI":"10.1007\/s10620-005-1282-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Vela MF, Craft BM, Sharma N, Freeman J, Hazen-Martin D. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol 2011; 106: 844\u2013850.","DOI":"10.1038\/ajg.2010.476"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Calabrese C, Bortolotti M, Fabbri A, et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol 2005; 100: 537\u2013542.","DOI":"10.1111\/j.1572-0241.2005.40476.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Kawahara H, Kubota A, Hasegawa T, et al. Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int 2007; 23: 1001\u20131005.","DOI":"10.1007\/s00383-007-1986-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Takeda H, Sadakane C, Hattori T, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008; 134: 2004\u20132013.","DOI":"10.1053\/j.gastro.2008.02.078"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Yakabi K, Sadakane C, Noguchi M, et al. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology 2010; 151: 3773\u20133782.","DOI":"10.1210\/en.2010-0061"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kusunoki H, Haruma K, Hata J, et al. Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med 2010; 49: 2195\u20132202.","DOI":"10.2169\/internalmedicine.49.3803"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Tatsuta M, Iishi H. Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993; 7: 459\u2013462.","DOI":"10.1111\/j.1365-2036.1993.tb00120.x"},{"key":"25","unstructured":"25 Hongo M, Miwa H, Ashida K, Kinoshita Y, Shigeru S, Fumio C. The development of a new questionnaire of health-related quality of life for reflux esophagitis. Prog Med 2008; 28: 2219\u20132224(in Japanese)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Tominaga K, Kato M, Takeda H, et al.; G-PRIDE Study Group. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol 2014; 49: 1392\u20131405.","DOI":"10.1007\/s00535-013-0896-9"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/60\/2\/60_16-77\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:02:00Z","timestamp":1498384920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/60\/2\/60_16-77\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.16-77","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}